Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “Chronic myeloid leukemia”
Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT00114959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease
ClinicalTrials.gov study NCT00267085. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02709083. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT05743465. IPD Sharing: YES. Countries: 1. Publications: 0.
Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous L
ClinicalTrials.gov study NCT01690520. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02807272. IPD Sharing: NO. Countries: 1. Publications: 0.
Pegasys in Patients With Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT01392170. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Trans
ClinicalTrials.gov study NCT00548847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03874858. IPD Sharing: YES. Countries: 1. Publications: 0.
Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT04006847. IPD Sharing: NO. Countries: 1. Publications: 0.
Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02730195. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT00067028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis
ClinicalTrials.gov study NCT00171158. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)
ClinicalTrials.gov study NCT05038800. IPD Sharing: YES. Countries: 3. Publications: 0.
A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib The
ClinicalTrials.gov study NCT00362466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT01218477. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia
GEO Series GSE177485. Homo sapiens. 10 samples. Type: Expression profiling by high throughput sequencing.
Chronic IL-15 stimulation and impaired mTOR signaling and metabolism in natural killer cells during acute myeloid leukemia
GEO Series GSE180409. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Chronic growth factor signaling in Acute Myeloid Leukemia is connected to a specific chromatin signature
GEO Series GSE64874. Homo sapiens. 51 samples. Type: Expression profiling by array; Genome binding/occupancy profiling by high throughput sequencing.
Comparison of microRNA Expression Profile in Patients Newly Diagnosed with Chronic Myeloid Leukemia and Treated by Allogeneic Hematopoietic Stem Cell Transplantation
GEO Series GSE148567. Homo sapiens. 29 samples. Type: Non-coding RNA profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.